Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183: 109119.
Magliano DJBE. IDF Diabetes Atlas. Brussels: International Diabetes Federation; 2021.
Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8–14.
Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007–2016. Arthritis Rheumatol. 2019;71(6):991–9.
Article PubMed PubMed Central Google Scholar
Nutmakul T. A review on benefits of quercetin in hyperuricemia and gouty arthritis. Saudi Pharm J. 2022;30(7):918–26.
Article CAS PubMed PubMed Central Google Scholar
Kim SC, Liu J, Solomon DH. Risk of incident diabetes in patients with gout: a cohort study. Arthritis Rheumatol. 2015;67(1):273–80.
Article PubMed PubMed Central Google Scholar
Wang T, Bi Y, Xu M, Huang Y, Xu Y, Li X, et al. Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine. 2011;40(1):109–16.
Article CAS PubMed Google Scholar
Choi HK, De Vera MA, Krishnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford). 2008;47(10):1567–70.
Article CAS PubMed Google Scholar
Tung YC, Lee SS, Tsai WC, Lin GT, Chang HW, Tu HP. Association Between Gout and Incident Type 2 Diabetes Mellitus: A Retrospective Cohort Study. Am J Med. 2016;129(11):e17–25.
•• Zhao R, Wang Y, Fu T, Zhou W, Ge X, Sha X, et al. Gout and risk of diabetes mellitus: meta-analysis of observational studies. Psychol Health Med. 2020;25(8):917–30. A meta-analysis discussing the prevalence of diabetes among patients with gout.
Chhana A, Lee G, Dalbeth N. Factors influencing the crystallization of monosodium urate: a systematic literature review. BMC Musculoskelet Disord. 2015;16:296.
Article PubMed PubMed Central Google Scholar
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 2000; 283(15): 2008–12.
Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.
Article PubMed PubMed Central Google Scholar
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
Article PubMed PubMed Central Google Scholar
Stewart S, Rome K, Eason A, House ME, Horne A, Doyle AJ, et al. Predictors of activity limitation in people with gout: a prospective study. Clin Rheumatol. 2018;37(8):2213–9.
Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2–10.
Chen SY, Chen CL, Shen ML. Manifestations of metabolic syndrome associated with male gout in different age strata. Clin Rheumatol. 2007;26(9):1453–7.
Chua CG, Thong BY. Inflammatory Arthritis Among Military Servicemen From a Rheumatology Center in Singapore. Mil Med 2021.
Hsu CY, Lin CL, Kao CH. Gout is associated with organic and psychogenic erectile dysfunction. Eur J Intern Med. 2015;26(9):691–5.
Janssens HJ, Arts PG, Schalk BW, Biermans MC. Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: A primary care retrospective cohort study. Joint Bone Spine. 2017;84(1):59–64.
Joo K, Kwon SR, Lim MJ, Jung KH, Joo H, Park W. Prevention of comorbidity and acute attack of gout by uric acid lowering therapy. J Korean Med Sci. 2014;29(5):657–61.
Article CAS PubMed PubMed Central Google Scholar
Primatesta P, Plana E, Rothenbacher D. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population. BMC Musculoskelet Disord. 2011;12:103.
Article PubMed PubMed Central Google Scholar
Chen SY, Chen CL, Shen ML, Kamatani N. Trends in the manifestations of gout in Taiwan. Rheumatology (Oxford). 2003;42(12):1529–33.
Chen Y, Cheng J, Chen Y, Wang N, Xia F, Chen C, et al. Association between serum vitamin D and uric acid in the eastern Chinese population: a population-based cross-sectional study. BMC Endocr Disord. 2020;20(1):79.
Article CAS PubMed PubMed Central Google Scholar
Collier A, Stirling A, Cameron L, Hair M, Crosbie D. Gout and diabetes: a common combination. Postgrad Med J. 2016;92(1089):372–8.
Article CAS PubMed Google Scholar
Hirsch JD, Terkeltaub R, Khanna D, Singh J, Sarkin A, Shieh M, et al. Gout disease-specific quality of life and the association with gout characteristics. Patient Relat Outcome Meas. 2010;2010:1–8.
Huang CC, Huang PH, Chen JH, Lan JL, Tsay GJ, Lin HY, et al. An Independent Risk of Gout on the Development of Deep Vein Thrombosis and Pulmonary Embolism: A Nationwide, Population-Based Cohort Study. Medicine (Baltimore). 2015;94(51): e2140.
Juraschek SP, Kovell LC, Miller ER 3rd, Gelber AC. Gout, urate-lowering therapy, and uric acid levels among adults in the United States. Arthritis Care Res (Hoboken). 2015;67(4):588–92.
Article CAS PubMed Google Scholar
Pang S, Jiang Q, Sun P, Li Y, Zhu Y, Liu J, et al. Hyperuricemia prevalence and its association with metabolic disorders: a multicenter retrospective real-world study in China. Ann Transl Med. 2021;9(20):1550.
Article CAS PubMed PubMed Central Google Scholar
Richette P, Clerson P, Périssin L, Flipo RM, Bardin T. Revisiting comorbidities in gout: a cluster analysis. Ann Rheum Dis. 2015;74(1):142–7.
Robinson PC, Merriman TR, Herbison P, Highton J. Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999–2009. Rheumatology (Oxford). 2013;52(1):118–26.
Roddy E, Muller S, Hayward R, Mallen CD. The association of gout with sleep disorders: a cross-sectional study in primary care. BMC Musculoskelet Disord. 2013;14:119.
Article PubMed PubMed Central Google Scholar
Schlesinger N, Radvanski DC, Cheng JQ, Kostis JB. Erectile Dysfunction Is Common among Patients with Gout. J Rheumatol. 2015;42(10):1893–7.
Article CAS PubMed Google Scholar
Scire CA, Manara M, Cimmino MA, Govoni M, Salaffi F, Punzi L, et al. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther. 2013;15(5):R101.
Article PubMed PubMed Central Google Scholar
Te Kampe R, Janssen M, van Durme C, Jansen TL, Boonen A. Sex Differences in the Clinical Profile Among Patients With Gout: Cross-sectional Analyses of an Observational Study. J Rheumatol. 2021;48(2):286–92.
Tee M, Lustre Ii C, Abrilla A, Afos IE, Cañal JP. Prevalence of Urolithiasis by Ultrasonography Among Patients with Gout: A Cross-Sectional Study from the UP-Philippine General Hospital. Res Rep Urol. 2020;12:423–31.
CAS PubMed PubMed Central Google Scholar
Yu Q, Shen HC, Hu YC, Chen YF, Tung TH. Prevalence and Metabolic Factors of Hyperuricemia in an Elderly Agricultural and Fishing Population in Taiwan. Arch Rheumatol. 2017;32(2):149–57.
Article PubMed PubMed Central Google Scholar
Golmohammadi S, Tavasoli M, Asadi N. Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver. Clin Exp Gastroenterol. 2020;13:299–304.
Article CAS PubMed PubMed Central Google Scholar
González-Senac NM, Bailén R, Torres RJ, de Miguel E, Puig JG. Metabolic syndrome in primary gout. Nucleosides Nucleotides Nucleic Acids. 2014;33(4–6):185–91.
Irfan M, Jawaid W, Hashmat O, Nisa Q, Khastoori DR 2nd, Shahbaz NN. Association Between Hyperuricemia and Acute Ischemic Stroke in Patients at a Tertiary Care Hospital. Cureus. 2020;12(10): e10899.
留言 (0)